These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22688939)

  • 1. Long-time octreotide in an adolescent with severe haemorrhagic gastrointestinal vascular malformation.
    Classen CF; Haffner D; Hauenstein C; Wolf R; Kyank U
    BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22688939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis.
    Goltstein LCMJ; Grooteman KV; Rocco A; Holleran G; Frago S; Salgueiro PS; Aparicio T; Scaglione G; Chetcuti Zammit S; Prados-Manzano R; Benamouzig R; Nardone G; McNamara D; Benallaoua M; Michopoulos S; Sidhu R; Kievit W; Drenth JPH; van Geenen EJM
    Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):922-932. PubMed ID: 34508668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients?
    Iannone A; Principi M; Barone M; Losurdo G; Ierardi E; Di Leo A
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):373-7. PubMed ID: 27595456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Octreotide and angiodysplasia].
    Fernández Salazar LI; de la Calle Valverde F; González Hernández JM
    Gastroenterol Hepatol; 2004 Nov; 27(9):558-9. PubMed ID: 15544743
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract.
    Nardone G; Rocco A; Balzano T; Budillon G
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1429-36. PubMed ID: 10571598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide long-active release in the treatment of gastrointestinal bleeding due to vascular malformations: Cost-effectiveness study.
    Klímová K; Padilla-Suárez C; Giménez-Manzorro Á; Pajares-Díaz JA; Clemente-Ricote G; Hernando-Alonso A
    Rev Esp Enferm Dig; 2015 Feb; 107(2):79-88. PubMed ID: 25659389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentre, open-label, randomised, parallel-group, superiority study to compare the efficacy of octreotide therapy 40 mg monthly versus standard of care in patients with refractory anaemia due to gastrointestinal bleeding from small bowel angiodysplasias: a protocol of the OCEAN trial.
    Grooteman KV; van Geenen EJ; Drenth JP
    BMJ Open; 2016 Sep; 6(9):e011442. PubMed ID: 27619827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Somatostatin analogues in the treatment of bleeding GI-angiodysplasias].
    Boesby L; Christensen NJ; Kristensen LO
    Ugeskr Laeger; 2008 Mar; 170(11):958. PubMed ID: 18397628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia.
    Junquera F; Saperas E; Videla S; Feu F; Vilaseca J; Armengol JR; Bordas JM; Piqué JM; Malagelada JR
    Am J Gastroenterol; 2007 Feb; 102(2):254-60. PubMed ID: 17311647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long acting release-octreotide as "rescue" therapy to control angiodysplasia bleeding: A retrospective study of 98 cases.
    Nardone G; Compare D; Scarpignato C; Rocco A
    Dig Liver Dis; 2014 Aug; 46(8):688-94. PubMed ID: 24893688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of refractory midgut bleeding with ocreotide and corticosteroids in a dialysis patient with suspected sarcoidosis.
    Velasco N; Imtiaz T; Shah AA; Koulaouzidis A
    BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27417989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent obscure gastrointestinal bleeding: dilemmas and success with pharmacological therapies. Case series and review.
    Almadi M; Ghali PM; Constantin A; Galipeau J; Szilagyi A
    Can J Gastroenterol; 2009 Sep; 23(9):625-31. PubMed ID: 19816627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Octreotide in the treatment of angiodysplasia in patients with advanced chronic renal failure].
    Rivera M; Lucero J; Guerrero A; Márquez JL; Montes R; Suñer M; Ruiz A; Valdivia MA; Mateos J
    Nefrologia; 2005; 25(3):332-5. PubMed ID: 16053016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic failure with thalidomide in patients with recurrent intestinal bleeding due to angiodysplasias.
    Izquierdo Navarro Mdel C; Hernando Verdugo M; Cardaba Garcia E; Sanchez Sanchez MT
    Farm Hosp; 2016 May; 40(3):230-2. PubMed ID: 27145393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Octreotide in Pediatric Gastrointestinal Bleeding Secondary to Angiodysplasia in Children With Right Heart Failure.
    Puri K; Caldwell RL; Molleston JP
    J Pediatr Gastroenterol Nutr; 2018 Feb; 66(2):e41-e44. PubMed ID: 28614113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide for recurrent intestinal bleeding due to ventricular assist device.
    Coutance G; Saplacan V; Belin A; Repessé Y; Buklas D; Massetti M
    Asian Cardiovasc Thorac Ann; 2014 Mar; 22(3):350-2. PubMed ID: 24585917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract.
    Orsi P; Guatti-Zuliani C; Okolicsanyi L
    Dig Liver Dis; 2001 May; 33(4):330-4. PubMed ID: 11432511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Octreotide in bleeding caused by intestinal angiodysplasia].
    Lourdes Ruiz Rebollo M; Barrio Andrés J; Fernández-Orcajo P; Prada Lobato J; Mena Martín FJ; Velicia Llames R; Caro-Paton A
    Gastroenterol Hepatol; 2008 Dec; 31(10):713-4. PubMed ID: 19174089
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-acting octreotide as rescue therapy in chronic bleeding from gastrointestinal angiodysplasia.
    Scaglione G; Pietrini L; Russo F; Franco MR; Sorrentini I
    Aliment Pharmacol Ther; 2007 Sep; 26(6):935-42. PubMed ID: 17767478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin analogues for bleeding gastrointestinal angiodysplasias: when should thalidomide be prescribed?
    Molina-Infante J; Perez-Gallardo B
    Dig Dis Sci; 2011 Jan; 56(1):266-7. PubMed ID: 21046246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.